SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-162770
Filing Date
2021-05-17
Accepted
2021-05-17 07:38:01
Documents
6
Period of Report
2021-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d120588d8k.htm 8-K 53682
2 EX-2.1 d120588dex21.htm EX-2.1 870619
3 EX-3.1 d120588dex31.htm EX-3.1 3303
4 EX-10.1 d120588dex101.htm EX-10.1 406418
5 EX-99.1 d120588dex991.htm EX-99.1 30041
6 GRAPHIC g120588g0517105617913.jpg GRAPHIC 4685
  Complete submission text file 0001193125-21-162770.txt   1372282
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 21927579
SIC: 2834 Pharmaceutical Preparations